Full Text
Promoting market access through breakthrough therapy designation- can this accolade help convince payers and prescribers?

Abstract

Authors

A. Duval J. Cox

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×